#Cytokinetics is one of the first drugmakers to benefit from the #UK's dual #regulatory and #reimbursement appraisals, getting a green light for its #obstructivehypertrophic ardiomyopathy (HCM) drug #Myqorzo.
Cytokinetics' cardiomyopathy drug cleared for NHS use
Cytokinetics gets simultaneous MHRA and NICE approvals for hypertrophic cardiomyopathy (HCM) therapy Myqorzo.
buff.ly
July 30, 2026 at 2:30 PM
#Cytokinetics is one of the first drugmakers to benefit from the #UK's dual #regulatory and #reimbursement appraisals, getting a green light for its #obstructivehypertrophic ardiomyopathy (HCM) drug #Myqorzo.